Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 30. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2055Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2056Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI80% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2057Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2058Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2059Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI80% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2060Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI30% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2061Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2062Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2063Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANANANANAAthymic hsd nude mice xenograft for PLC cell line5.0E+6 pfuReduction in tumor volume below 2000mm compared to control after 45 days No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2534AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI100% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2535AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI90% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2536AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI30% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2545AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI100% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2546AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2547AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI40% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2548AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI10% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2591AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2597AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNACrystal violet staining0.1 MOI100% cells viavilityNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2598AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNACrystal violet staining1 MOISome cells are viableNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2599AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNACrystal violet staining10 MOI100% cell deathNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2600AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNACrystal violet staining100 MOI100% cell deathNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2731AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI100% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2732AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2733AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI60% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2734AdenovirusAdCN205DNAAdenoviridaeNoneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI50% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2735AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI90% cell viability after 24 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2736AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI80% cell viability after 48 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2737AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI50% cell viability after 72 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_2738AdenovirusAdCN205DNAAdenoviridaeNoneNoVirus strain in combination with miR-34-aVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell linePLC51.0E+4 cells per wellNAMTT assay5 MOI30% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosis, G1 arrest and sensescenceInhibition of oncogene and antiapototic geneNA23292172
OV_4312AlphavirusM1RNATogaviridaeNoneYesNoNoSICBHuman hepatomaPLC4000 cells per wellNAMTT assay10 pfu80.5 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347